Patent details

EP2238251 Title: SILENCING OF POLO-LIKE KINASE EXPRESSION USING INTERFERING RNA

Basic Information

Publication number:
EP2238251
PCT Application Number:
PCT/CA/2008/002285
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP088670070
PCT Publication Number:
WO/2009/082817
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SILENCING OF POLO-LIKE KINASE EXPRESSION USING INTERFERING RNA
French Title of Invention:
SILENÇAGE DE L'EXPRESSION DE LA POLO-LIKE KINASE À L'AIDE D'UN ARN INTERFÉRENT
German Title of Invention:
SILENCING DER POLO-LIKE-KINASE-EXPRESSION UNTER VERWENDUNG VON INTERFERENZ-RNA
SPC Number:

Dates

Filing date:
23/12/2008
Grant date:
11/02/2015
EP Publication Date:
11/02/2015
PCT Publication Date:
09/07/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/10/2010
EP B1 Publication Date:
11/02/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/12/2015
Expiration date:
23/12/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/12/2008
 
 

Name:
Protiva Biotherapeutics Inc.
Address:
100-8900 Glenlyon Parkway, Burnaby, British Columbia V5J 5J8, Canada (CA)

Inventor

1

Name:
JUDGE Adam
Address:
Canada (CA)

2

Name:
MACLACHLAN Ian
Address:
Canada (CA)

Priority

1

Priority Number:
17075 P
Priority Date:
27/12/2007
Priority Country:
United States (US)

2

Priority Number:
45228 P
Priority Date:
15/04/2008
Priority Country:
United States (US)

3

Priority Number:
100653 P
Priority Date:
26/09/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
C12N 15/113;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages